KMT5A and ovarian carcinoma: Moreover, we found that the IC50 for cisplatin on breast and ovarian cancer cell-lines in the GDSC database depends on the expression level of SETD8 (https://www.cancerrxgene.org/, data access date: July 2019) [47] (supplementary Fig. S4I-J).